Germany (*) has now joined the list.
France (*) will probably join soon.
Oxford University’s brand managers seem to have told the British media to stop calling it the “Oxford jab” and to call it the “Astrazeneca” instead. Bit of a balls-up for Oxford’s public relations.
@ET: your rhetorical techniques: “temporary”, “one particular batch”, “no direct evidence”, “awaiting further evaluation”, you have “yet to see verification”. The fact is that a growing number of foreign countries are cutting back on shooting this vaccine into people, owing to blood clotting and deaths, and the British press are saying that that’s because the foreigners aren’t expert enough, can’t think straight, or are in some other way up their own a*ses.
Meanwhile in Britain (presumed source of the Britain variant B117) the Astrazeneca vaccine is even being given to those who are known to have had SARS-CoV2, who experienced symptoms, including in many cases severe symptoms, and who then recovered.
Among those known to have been infected with SARS-CoV2 and who experienced symptoms and recovered, the reinfection rate is probably much higher among the vaccinated than among the unvaccinated. I haven’t seen a figure, but that’s certainly what it sounds like.
The country in which such an unusually large proportion of people have DIED with Covid-19 is the very same country in which a vaccine has been developed which numerous other countries have cut back on or stopped doling out…and soon we may find that the only “market” left for it (perhaps excluding places such as Gibraltar and the Falkland Islands) is those who live inside the country who believe the country’s own “experts” and government leaders and who are told to take it by medics, whose contempt towards working class patients will grow from its already extremely high levels whenever such a patient even asks the question “which vaccine is it that you want to give me?”